The 3 Big MSOs Report Q2

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in the past, but we post this and all of the newsletters on our website here.

Friends,

Q2 earnings season for MSOs kicked off yesterday, with the three largest MSOs sharing updates through press releases and conference calls. This website shared recently the outlooks for the reports:

The outlooks were dim. Trulieve reported before the market opened on Wednesday, and both revenue and adjusted EBITDA were higher than expected but not very exciting. The Q3 guidance was soft. The company ended Q2 with net debt fell of just $85.3 million, but this doesn’t include the $746 million in tax-related liabilities. GTI and Curaleaf reported on Wednesday afternoon and had conference calls at the exact same time (GTI announced its timing on July 2nd in the morning, and Curaleaf scheduled it on July 8th for the same time). GTBIF had a weak quarter, with margins declining. The company is suspending its quarterly conference calls going ahead. Curaleaf had a weak quarter, but it hit the estimates.

In 2025, Curaleaf is up in price now after having been way down earlier this year. Here are the returns quarter-to-date and year-to-date for these three companies:

MSOS is up 37.8% in Q3 but down 12.9% in 2025 so far, closing at $3.30. It has very large positions in each of these three MSOs, which make up 69.4% of the portfolio currently. The NCV Global Cannabis Stock Index has declined 19.5% so far in 2025 and has rallied by 10.4% thus far in Q3.

MSOS has seen its share-count increase recently after declining in the Spring, and has a share-count now of 150.275 million, up 15.1% year-to-date. It has boosted its ownership in two of the Big 3 MSOs in 2025:

I continue to be very cautious on the MSOs and think that investors should exit MSOS and each of these three MSOs too. There are better ways to invest in cannabis.

Sincerely,

Alan

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published this past week:

Exclusives

Cannabis Sales Were Soft in July

Cannabis Stocks Soared in July

Financial Reports

Curaleaf Q2 Revenue Falls 8%

Green Thumb Industries Q2 Revenue Increases 5%

Trulieve Q2 Revenue Flat

Mergers & Acquisitions

IIPR Extends Beyond Cannabis

To get real-time updates, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor calendar.